Your browser doesn't support javascript.
loading
Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study.
Capasso, Nicola; Palladino, Raffaele; Cerbone, Vincenza; Spiezia, Antonio Luca; Covelli, Bianca; Fiore, Antonia; Lanzillo, Roberta; Carotenuto, Antonio; Petracca, Maria; Stanziola, Lucia; Scalia, Giulia; Brescia Morra, Vincenzo; Moccia, Marcello.
Afiliação
  • Capasso N; Multiple Sclerosis Unit, Federico II University Hospital, Via Sergio Pansini 5, 80131, Naples, Italy.
  • Palladino R; Department of Public Health, Federico II University of Naples, Naples, Italy.
  • Cerbone V; Centre for Advanced Biotechnology (CEINGE), Naples, Italy.
  • Spiezia AL; Multiple Sclerosis Unit, Federico II University Hospital, Via Sergio Pansini 5, 80131, Naples, Italy.
  • Covelli B; Department of Neuroscience, Reproductive Sciences and Odontostomatology, Federico II University of Naples, Naples, Italy.
  • Fiore A; Department of Translational Medical Sciences, Federico II University of Naples, Naples, Italy.
  • Lanzillo R; Centre for Advanced Biotechnology (CEINGE), Naples, Italy.
  • Carotenuto A; Multiple Sclerosis Unit, Federico II University Hospital, Via Sergio Pansini 5, 80131, Naples, Italy.
  • Petracca M; Department of Neuroscience, Reproductive Sciences and Odontostomatology, Federico II University of Naples, Naples, Italy.
  • Stanziola L; Multiple Sclerosis Unit, Federico II University Hospital, Via Sergio Pansini 5, 80131, Naples, Italy.
  • Scalia G; Department of Neuroscience, Reproductive Sciences and Odontostomatology, Federico II University of Naples, Naples, Italy.
  • Brescia Morra V; Multiple Sclerosis Unit, Federico II University Hospital, Via Sergio Pansini 5, 80131, Naples, Italy.
  • Moccia M; Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
J Neurol ; 270(1): 272-282, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36048265

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália País de publicação: Alemanha